V. P. Prasher

Molecular mapping of alzheimer‐type dementia in Down's syndrome

V. P. Prasher, Matthew J. Farrer, Anna M. Kessling et al. · Annals of Neurology · 1998 · 409 citations · Full text

Genetics, Neurochemical Biomarkers, Amyloid Precursor Protein +19

Memantine for dementia in adults older than 40 years with Down's syndrome (MEADOWS): a randomised, double-blind, placebo-controlled trial

Marisa Hanney, V. P. Prasher, Nicola Williams et al. · The Lancet · 2012 · 162 citations

Alzheimer's Disease, Aging, Psychiatry +10

A 24‐week, double‐blind, placebo‐controlled trial of donepezil in patients with Down syndrome and Alzheimer's disease—pilot study

V. P. Prasher, Adam Huxley, Sayeed Haque · International Journal of Geriatric Psychiatry · 2002 · 152 citations

TDP-43 pathological changes in early onset familial and sporadic Alzheimer’s disease, late onset Alzheimer’s disease and Down’s Syndrome: association with age, hippocampal sclerosis and clinical phenotype

Yvonne S. Davidson, Samantha Raby, Penelope G. Foulds et al. · Acta Neuropathologica · 2011 · 151 citations

Down Syndrome, Neurodegenerative Diseases, Alzheimer's Disease +12

Overweight and obesity amongst Down's syndrome adults

V. P. Prasher · Journal of Intellectual Disability Research · 1995 · 150 citations

Down Syndrome, Obesity, Childhood Obesity +12